You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance

Article metrics

Article menu
XML
Basic tumor immunology
Original research
Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance

 

Online download statistics by month:

Online download statistics by month: October 2020 to November 2024

AbstractFullPdf
Oct 2020499499327
Nov 2020232232118
Dec 202011411476
Jan 202113613655
Feb 202121821843
Mar 202117017089
Apr 202110810850
May 202111011071
Jun 2021818068
Jul 2021676749
Aug 2021808057
Sep 2021919152
Oct 202115015094
Nov 202110610776
Dec 2021899154
Jan 202214014543
Feb 202210511669
Mar 202216517694
Apr 202211211961
May 202213014466
Jun 2022959945
Jul 2022727328
Aug 202212312758
Sep 2022117117304
Oct 202210811785
Nov 202213313371
Dec 2022929243
Jan 202313213465
Feb 202316016354
Mar 202312012159
Apr 2023868634
May 2023919632
Jun 2023979733
Jul 202311111145
Aug 2023919043
Sep 2023828240
Oct 2023646434
Nov 2023777737
Dec 2023919138
Jan 2024545631
Feb 2024696931
Mar 20248589128
Apr 20249810047
May 2024636941
Jun 2024737245
Jul 2024848643
Aug 2024979532
Sep 2024112119298
Oct 2024939440
Nov 2024747540
Total574758473536